Julia Bader

Also affiliated with Freie Universität Berlin

Materials ScienceChemistryPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “134TiP: Evaluation of an additional cohort of patients with non-small cell lung cancer (NSCLC) in the phase I/II duravelo-1 study of zelenectide pevedotin (BT8009), a bicycle toxin conjugate”.

134TiP: Evaluation of an additional cohort of patients with non-small cell lung cancer (NSCLC) in the phase I/II duravelo-1 study of zelenectide pevedotin (BT8009), a bicycle toxin conjugate

Journal of Thoracic Oncology(2025)10.1016/s1556-0864(25)00329-6

N/A

0DataRank · unranked

0 citations

Loïc Verlingue, A. Italiano, L. Carter, Gerald S. Falchook, Valentina Boni +13 more

414TiP Phase I/II study (Duravelo-1) of zelenectide pevedotin, a Bicycle Toxin Conjugate: Additional cohort (B-8) in patients with advanced breast cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104985

N/A

0DataRank · unranked

0 citations

G.S. Falchook, Loïc Verlingue, L. Carter, Thibault De La Motte Rouge, C. Baldini +14 more